- [Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services<p>This podcast explores how clinical trial supplies move from early planning to global delivery, ensuring investigational medicines reach patients safely and on time.</p>BioPharma Dive · 7d ago↗ source
- Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trialA phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study scheduled to report data in October, the biotech is holding off on…Fierce Biotech · 7d ago↗ source
- Tempus buys out cancer genomics partner Personalis in $1.5 billion dealTempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology.